Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Aminofurazans as potent inhibitors of AKT kinaseMeagan B Rouse, Mark A Seefeld, Jack D Leber, et al.Molecular Neurobiology|September 12, 2023
Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer's-Like Disease in Transgenic MiceFengjun Liu, Zhifei Wang, Delei Niu, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazolesHong Lin, Dennis S Yamashita, Jin Zeng, et al.Molecular Cancer Therapeutics|April 8, 2010
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancerWilliam M Merritt, Alpa M Nick, Amy R Carroll, et al.Journal of Zhejiang University. Science. B|March 7, 2024
Newcastle disease virus suppresses antigen presentation via inhibiting IL-12 expression in dendritic cellsFulong Nan, Wenlong Nan, Xin Yan, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.Pageof 8